About Spermatogenesis-associated protein 21
Spermatogenesis-associated protein 21 (SPATA21) is a protein
from Homo sapiens identified by UniProt accession
Q7Z572, 469 residues long.
MolForge cross-references it against 0 known binders and
17 disease associations.
Target properties
| Protein name | Spermatogenesis-associated protein 21 |
| UniProt accession | Q7Z572 |
| Gene | SPATA21 |
| Organism | Homo sapiens |
| Length | 469 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (17)
Diseases linked to this target (Open Targets).
- body fat percentage · score 0.06
- body mass index · score 0.06
- balding measurement · score 0.06
- Inguinal hernia · score 0.06
- fat body mass · score 0.05
- neutrophil percentage of leukocytes · score 0.05
- hair shape measurement · score 0.04
- pulmonary vascular congestion · score 0.03
- cortical surface area measurement · score 0.03
- lymphocyte percentage of leukocytes · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q7Z572-F1 | alphafold | PREDICTED | 59.19 | — |
Amino-acid sequence (469 residues)
MDNRNTQMYT EEEKTVNPFL PSTPGPKKAK GGGEAVETHP APGPLPPPEV RDIGERREPD RAQQQPQKPA VAAGTQSLGN FRQGFMKCLL EVEKMEASHR RASKARSQTA QKSPRTLTPV PTSAPSLPQT PASVPASGPS WARLPAPGPE PAPMGAPVPT SMPCPVLLGP ALDLGWRRME LLHQSSERTL SYAKARQEPE EQSLQKLYQN REKSEEQLTL KQEEAFRSYF EIFNGPGEVD AQSLKNILLL MGFSVTLAQV EDALMSADVN GDGRVDFKDF LAVMTDTRRF FCSVEQNALS DMAPHNPHTL LFEILSLLVE MLALPEAVLE EITNYYQKKL KEGTCKAQEM EAAVGRLRLQ KLPYNPQQEE SSEVPERKVL SILSRLKQQN YAPNLQSPYA QVPCILLCPQ LDKKMVRRQP SNHYALDQCT PPGLDPDIRS PFFQSGSQGN REHNSDSRKW LSSVPARTH
Explore Spermatogenesis-associated protein 21 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets